Atlas Trials

Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway

Clinical trial NCT01499940 · TERMINATED

Trial details

NCT number
NCT01499940
Sponsor
Gerald Higa, PharmD.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Neurotoxicity
Start date
2012-01-01
Primary completion
2012-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.